Neuland Laboratories share news, announcements and annual reports
NSE: NEULANDLABBSE: 524558Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹19,970.00.
29 Oct: open ₹19,995.00, high ₹20,015.00, low ₹19,130.00
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹24,736 Cr356th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 49.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 13.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.18%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 29.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 32.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 71,65457.6% delivered
Neuland Laboratories share news and announcements
837 announcements, routine notices left out, newest first. Page 8 of 17.
Jun 2020
4 Jun · Related Party Transactions
May 2020
22 May · Business
22 May · Board meeting
22 May · Results
15 May · Business
14 May · Board meeting
7 May · Updates
Apr 2020
30 Apr · Disclosure
28 Apr · Rating
10 Apr · Legal
The exchange asked on 9 Apr 2020
Mar 2020
19 Mar · Analysts
Feb 2020
11 Feb · Board meeting
11 Feb · Business
11 Feb · Results
7 Feb · Updates
5 Feb · Corporate action
Jan 2020
24 Jan · Analysts
16 Jan · Board meeting
Dec 2019
9 Dec · Registrar & Share Transfer Agent Update
5 Dec · Analysts
Nov 2019
14 Nov · Results
14 Nov · Business
14 Nov · Board meeting
7 Nov · Analysts
Oct 2019
30 Oct · Board meeting
Aug 2019
30 Aug · Updates
23 Aug · Analysts
14 Aug · Business
13 Aug · Business
13 Aug · Board meeting
13 Aug · Results
8 Aug · Analysts
2 Aug · Rating
Jul 2019
17 Jul · Business
16 Jul · Board meeting